Deferasirox Oral Granules
- Product NDC
- 72647-372
- 11-digit product format
- 726470372
- Labeler code
- 72647
- Product ID
- 72647-372_b170a73b-628d-4c59-b837-768812fbdd6c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- OAKRUM PHARMA, LLC
- Application
- ANDA214559
- Marketing category
- ANDA
- Marketing start
- 2021-03-09
- Marketing end
- 2024-01-31
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72647-372-30 | 72647037230 | 30 PACKET in 1 CARTON (72647-372-30) > 1 GRANULE in 1 PACKET | 30 packet | 2021-03-09 | 2024-01-31 | No | No | Current |